• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

服用睾酮的跨性别男性的内皮功能受损。

Compromised endothelial function in transgender men taking testosterone.

机构信息

Department of Medicine, Section of Endocrinology, Yale School of Medicine, New Haven, CT, USA.

Yale Department of Obstetrics, Gynecology and Reproductive Sciences. and Gynecology, Yale School of Medicine, New Haven, CT, USA.

出版信息

Clin Endocrinol (Oxf). 2020 Feb;92(2):138-144. doi: 10.1111/cen.14132. Epub 2019 Dec 13.

DOI:10.1111/cen.14132
PMID:31765022
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6957681/
Abstract

CONTEXT

Transgender men (TGM) are persons assigned female gender at birth with a male gender identity and are routinely treated with testosterone. Androgen excess is associated with endothelial dysfunction among cisgender females (CGF) and is an early sign of atherosclerosis and hypertension.

OBJECTIVE

To determine the effect of testosterone treatment on endothelial function in TGM.

SETTING

The John B. Pierce Laboratory and Yale School of Medicine.

SUBJECTS

Eleven TGM (age 27 ± 5 years; BMI 24.4 ± 3.7 kg/m ) receiving testosterone (T) and 20 CGF (28 ± 5 years; BMI 26.0 ± 5.1 kg/m ) during the early follicular phase of their menstrual cycle.

DESIGN AND OUTCOME MEASURES

We evaluated brachial vasodilatory responses following stimuli designed to elicit shear stress using 5-minute occlusion to determine endothelial function (flow-mediated vasodilation, FMD).

RESULTS

Total T was greater in the TGM compared to CGF (484.6 ± 122.5 vs 1.5 ± 0.7 ng/dL), as was free T (83.9 ± 32.4 vs 1.9 ± 0.8 pg/dL). FMD was markedly lower in the TGM (4.5 ± 2.7%) compared to the CGF (8.1 ± 2.9%, P = .002) indicating significantly diminished endothelial function in TGM.

CONCLUSIONS

We have shown for the first time that in TGM the androgen-dominant hormonal milieu was associated with impaired endothelial function. Endothelial dysfunction precedes clinically detectable atherosclerotic plaque in the coronary arteries, so is an important marker for clinical cardiovascular risk. Therefore, attention to cardiovascular risk factors should be integral to the care of transgender men.

摘要

背景

跨性别男性(TGM)是指出生时被指定为女性性别但具有男性性别认同的人,他们通常接受睾酮治疗。在顺性别女性(CGF)中,雄激素过多与血管内皮功能障碍有关,是动脉粥样硬化和高血压的早期征象。

目的

确定睾酮治疗对 TGM 内皮功能的影响。

设置

约翰·B·皮尔斯实验室和耶鲁大学医学院。

受试者

11 名接受睾酮(T)治疗的 TGM(年龄 27 ± 5 岁;BMI 24.4 ± 3.7 kg/m )和 20 名处于月经周期早期卵泡期的 CGF(28 ± 5 岁;BMI 26.0 ± 5.1 kg/m )。

设计和结果测量

我们通过 5 分钟的闭塞来评估肱动脉舒张反应,以确定内皮功能(血流介导的血管舒张,FMD),从而评估刺激引起的剪切应力下的血管舒张反应。

结果

与 CGF 相比,TGM 的总睾酮(484.6 ± 122.5 与 1.5 ± 0.7 ng/dL)和游离睾酮(83.9 ± 32.4 与 1.9 ± 0.8 pg/dL)更高。TGM 的 FMD 明显低于 CGF(4.5 ± 2.7%比 8.1 ± 2.9%,P =.002),表明 TGM 的内皮功能明显受损。

结论

我们首次表明,在 TGM 中,雄激素占主导地位的激素环境与内皮功能障碍有关。内皮功能障碍先于冠状动脉中可检测到的动脉粥样硬化斑块,因此是临床心血管风险的重要标志物。因此,关注心血管危险因素应成为跨性别男性护理的重要组成部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d436/6957681/bb560082915e/nihms-1061355-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d436/6957681/2e853525ccdc/nihms-1061355-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d436/6957681/bb560082915e/nihms-1061355-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d436/6957681/2e853525ccdc/nihms-1061355-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d436/6957681/bb560082915e/nihms-1061355-f0002.jpg

相似文献

1
Compromised endothelial function in transgender men taking testosterone.服用睾酮的跨性别男性的内皮功能受损。
Clin Endocrinol (Oxf). 2020 Feb;92(2):138-144. doi: 10.1111/cen.14132. Epub 2019 Dec 13.
2
Vascular reactivity is impaired in genetic females taking high-dose androgens.服用高剂量雄激素的遗传雌性动物的血管反应性受损。
J Am Coll Cardiol. 1998 Nov;32(5):1331-5. doi: 10.1016/s0735-1097(98)00416-1.
3
Persistent vaginal bleeding during gender-affirming hormone therapy in transgender men.跨性别男性在接受性别肯定激素治疗期间持续阴道出血。
J Endocrinol Invest. 2024 Aug;47(8):2053-2060. doi: 10.1007/s40618-023-02296-w. Epub 2024 Feb 1.
4
Endocrinological and ovarian histological investigations in assigned female at birth transgender people undergoing testosterone therapy.指定出生为女性的跨性别者在接受睾酮治疗时的内分泌和卵巢组织学研究。
Reprod Biomed Online. 2021 Aug;43(2):289-297. doi: 10.1016/j.rbmo.2021.05.010. Epub 2021 May 24.
5
Effect of estrogen on endothelial dysfunction in postmenopausal women with diabetes.雌激素对绝经后糖尿病女性内皮功能障碍的影响。
Diabetes Res Clin Pract. 2001 Dec;54 Suppl 2:S81-92. doi: 10.1016/s0168-8227(01)00339-4.
6
Androgen deficiency and endothelial dysfunction in men with end-stage kidney disease receiving maintenance hemodialysis.接受维持性血液透析的终末期肾病男性患者的雄激素缺乏与内皮功能障碍
Am J Nephrol. 2006;26(6):536-43. doi: 10.1159/000097816. Epub 2006 Dec 6.
7
Gender-affirming hormone therapy for transgender and gender-diverse adults in Australia.澳大利亚跨性别和性别多样化成年人的性别肯定激素治疗。
Intern Med J. 2024 Sep;54(9):1450-1457. doi: 10.1111/imj.16413. Epub 2024 Jul 26.
8
Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease.全身性内皮功能障碍与冠状动脉疾病的范围和严重程度相关。
Atherosclerosis. 1997 Feb 28;129(1):111-8. doi: 10.1016/s0021-9150(96)06018-2.
9
Blood pressure predicts endothelial function and the effects of ethinyl estradiol exposure in young women.血压可预测年轻女性的内皮功能和炔雌醇暴露的影响。
Am J Physiol Heart Circ Physiol. 2018 Oct 1;315(4):H925-H933. doi: 10.1152/ajpheart.00188.2018. Epub 2018 Jun 15.
10
Ovarian, breast, and metabolic changes induced by androgen treatment in transgender men.雄激素治疗对跨性别男性的卵巢、乳腺和代谢的影响。
Fertil Steril. 2021 Oct;116(4):936-942. doi: 10.1016/j.fertnstert.2021.07.1206. Epub 2021 Sep 2.

引用本文的文献

1
Impact of Testosterone on Endothelial Function Varies by GnRH Agonist Treatment.睾酮对内皮功能的影响因促性腺激素释放激素激动剂治疗而异。
J Endocr Soc. 2025 May 13;9(7):bvaf086. doi: 10.1210/jendso/bvaf086. eCollection 2025 Jul.
2
Getting to the Heart of the Matter: Exploring the Intersection of Cardiovascular Disease, Sex and Race and How Exercise, and Gut Microbiota Influence these Relationships.直击问题核心:探索心血管疾病、性别与种族的交叉点,以及运动和肠道微生物群如何影响这些关系。
Rev Cardiovasc Med. 2025 Feb 20;26(2):26430. doi: 10.31083/RCM26430. eCollection 2025 Feb.
3
Artificial intelligence evaluation of electrocardiographic characteristics and interval changes in transgender patients on gender-affirming hormone therapy.

本文引用的文献

1
Androgens drive microvascular endothelial dysfunction in women with polycystic ovary syndrome: role of the endothelin B receptor.雄激素导致多囊卵巢综合征女性微血管内皮功能障碍:内皮素 B 受体的作用。
J Physiol. 2019 Jun;597(11):2853-2865. doi: 10.1113/JP277756. Epub 2019 Mar 27.
2
Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan.性别差异对血管健康和整个生命周期中心血管疾病风险的内皮功能很重要。
Am J Physiol Heart Circ Physiol. 2018 Dec 1;315(6):H1569-H1588. doi: 10.1152/ajpheart.00396.2018. Epub 2018 Sep 14.
3
Blood pressure predicts endothelial function and the effects of ethinyl estradiol exposure in young women.
人工智能对接受性别确认激素治疗的跨性别患者心电图特征及间期变化的评估
Eur Heart J Digit Health. 2024 Oct 15;6(1):55-62. doi: 10.1093/ehjdh/ztae076. eCollection 2025 Jan.
4
Gender-affirming hormone therapy: effects on cardiovascular risk and vascular function.性别肯定激素疗法:对心血管风险和血管功能的影响。
Endocr Connect. 2024 Nov 25;14(2). doi: 10.1530/EC-24-0222.
5
Risk Factors for Acute Intraoperative Bradycardia in Patients Undergoing Gender-affirming Mastectomy.性别肯定性乳房切除术患者术中急性心动过缓的危险因素
Plast Surg (Oakv). 2024 Oct 9:22925503241285458. doi: 10.1177/22925503241285458.
6
The Cardiometabolic Risk in Women with Polycystic Ovarian Syndrome (PCOS): From Pathophysiology to Diagnosis and Treatment.多囊卵巢综合征(PCOS)女性的心脏代谢风险:从病理生理学到诊断和治疗。
Medicina (Kaunas). 2024 Oct 10;60(10):1656. doi: 10.3390/medicina60101656.
7
Cardiometabolic Risk Assessment in Transgender Individuals-Differential Effect of Sex Hormones and Sex Chromosomes.跨性别者的心脏代谢风险评估——性激素和性染色体的差异效应
J Clin Endocrinol Metab. 2025 Jun 17;110(7):e2273-e2284. doi: 10.1210/clinem/dgae745.
8
Testosterone supplementation and stroke in young adults: a review of the literature.年轻成年人中的睾酮补充与中风:文献综述
Front Neurol. 2024 Sep 2;15:1422931. doi: 10.3389/fneur.2024.1422931. eCollection 2024.
9
Guidelines on the use of sex and gender in cardiovascular research.心血管研究中性别和性别的使用指南。
Am J Physiol Heart Circ Physiol. 2024 Jan 1;326(1):H238-H255. doi: 10.1152/ajpheart.00535.2023. Epub 2023 Nov 24.
10
Cardiovascular Risk Factors in Transgender People after Gender-Affirming Hormone Therapy.性别肯定激素治疗后跨性别者的心血管危险因素
J Clin Med. 2023 Sep 23;12(19):6141. doi: 10.3390/jcm12196141.
血压可预测年轻女性的内皮功能和炔雌醇暴露的影响。
Am J Physiol Heart Circ Physiol. 2018 Oct 1;315(4):H925-H933. doi: 10.1152/ajpheart.00188.2018. Epub 2018 Jun 15.
4
Addition of Estradiol to Cross-Sex Testosterone Therapy Reduces Atherosclerosis Plaque Formation in Female ApoE-/- Mice.雌二醇联合跨性别雄激素治疗可减少载脂蛋白 E 基因敲除雌性小鼠动脉粥样硬化斑块的形成。
Endocrinology. 2018 Feb 1;159(2):754-762. doi: 10.1210/en.2017-00884.
5
Impaired Arginine Metabolism Coupled to a Defective Redox Conduit Contributes to Low Plasma Nitric Oxide in Polycystic Ovary Syndrome.精氨酸代谢受损与氧化还原通道缺陷共同导致多囊卵巢综合征患者血浆一氧化氮水平降低。
Cell Physiol Biochem. 2017;43(5):1880-1892. doi: 10.1159/000484107. Epub 2017 Oct 20.
6
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.性别焦虑/性别不一致者的内分泌治疗:内分泌学会临床实践指南
J Clin Endocrinol Metab. 2017 Nov 1;102(11):3869-3903. doi: 10.1210/jc.2017-01658.
7
Sex Steroids and Cardiovascular Outcomes in Transgender Individuals: A Systematic Review and Meta-Analysis.变性者的性类固醇与心血管结局:一项系统评价和荟萃分析。
J Clin Endocrinol Metab. 2017 Nov 1;102(11):3914-3923. doi: 10.1210/jc.2017-01643.
8
Cardiovascular Disease Among Transgender Adults Receiving Hormone Therapy: A Narrative Review.跨性别成年人接受激素治疗后的心血管疾病:叙事性综述。
Ann Intern Med. 2017 Aug 15;167(4):256-267. doi: 10.7326/M17-0577. Epub 2017 Jul 25.
9
Cardiovascular autonomic dysfunction in women with polycystic ovary syndrome: a systematic review and meta-analysis.多囊卵巢综合征女性的心血管自主神经功能障碍:一项系统评价和荟萃分析。
Reprod Biomed Online. 2017 Jul;35(1):113-120. doi: 10.1016/j.rbmo.2017.03.018. Epub 2017 Apr 7.
10
Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial. Testosterone 治疗 3 年对低或正常低水平睾酮的老年男性亚临床动脉粥样硬化进展的影响:一项随机临床试验。
JAMA. 2015 Aug 11;314(6):570-81. doi: 10.1001/jama.2015.8881.